发明名称 GLUCAGON ANALOGUES
摘要 The invention provides glucagon analogue peptides and their use for promoting weight loss or preventing weight gain, and the treatment of obesity or excess body weight and associated conditions. The compounds may also be used to improve glycemic control and/or for the treatment of diabetes. The compounds may mediate their effect, inter alia, by having increased selectivity for the GLP-1 receptor as compared to human glucagon.
申请公布号 US2016347813(A1) 申请公布日期 2016.12.01
申请号 US201615239154 申请日期 2016.08.17
申请人 Zealand Pharma A/S ;Boehringer Ingelheim International GmbH 发明人 HAMPRECHT Dieter Wolfgang;TOLBORG Jakob Lind;RIBER Ditte
分类号 C07K14/605;A61K45/06;A61K38/26 主分类号 C07K14/605
代理机构 代理人
主权项 1. A compound having the formula R1—X—Z—R2 wherein R1 is H, C1-4 alkyl, acetyl, formyl, benzoyl or trifluoroacetyl; R2 is OH or NH2; X is a peptide which has the formula I: His-X2-X3-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-X12-Tyr-Leu-Asp-X16-Arg-Arg-Ala-X20-Asp-Phe-Ile-X24-Trp-Leu-X27-X28-X29  (I) wherein X2 is selected from Ser, D-Ser and Aib; X3 is selected from Gln, His and Pro; X12 is selected from Lys and Y X16 is selected from Glu and Y; X20 is selected from Lys and Y; X24 is selected from Glu and Y; X27 is selected from Leu and Y; X28 is selected from Ser and Y or is absent; X29 is Ala or absent; wherein at least one of X12, X16, X17, X20, X27 and X28 is Y; wherein each residue Y is independently selected from Lys, Cys and Orn; wherein the side chain of at least one amino acid residue Y is conjugated to a lipophilic substituent having the formula: (i) Z1, wherein Z1 is a lipophilic moiety conjugated directly to the side chain of Y; or (ii) Z1Z2, wherein Z1 is a lipophilic moiety, Z2 is a spacer, and Z1 is conjugated to the side chain of Y via Z2; and Z is absent or is a sequence of 1-20 amino acid units independently selected from the group consisting of Ala, Leu, Ser, Thr, Tyr, Cys, Glu, Lys, Arg, Dbu, Dpr and Orn; or a pharmaceutically acceptable salt thereof.
地址 Glostrup DK
您可能感兴趣的专利